Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA

Warren, Luigi, Manos, Philip D., Ahfeldt, Tim, Loh, Yuin-Han, Li, Hu, Lau, Frank, Ebina, Wataru, Mandal, Pankaj K. +8 more·2010·Cell Stem Cell
DOI 10.1016/j.stem.2010.08.012

Cited by (1,006)

Items 101–200 of 1,006

  1. From the RNA world to the clinic
    Sullenger, Bruce A., Nair, Smita · 2016 · Science
  2. The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines
    Pedro Morais, Hironori Adachi, Yi‐Tao Yu · 2021 · Frontiers in Cell and Developmental Biology
  3. Circular RNA vaccine in disease prevention and treatment
    Dun Niu, Yaran Wu, Jiqin Lian · 2023 · Signal Transduction and Targeted Therapy
  4. Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
    Robinson, Ema, MacDonald, Kelvin D., Slaughter, Kai, McKinney, Madison, Patel, Siddharth, Sun, Conroy, Sahay, Gaurav · 2018 · Molecular Therapy
  5. Myc Depletion Induces a Pluripotent Dormant State Mimicking Diapause
    Scognamiglio, Roberta, Cabezas-Wallscheid, Nina, Thier, Marc Christian, Altamura, Sandro, Reyes, Alejandro, Prendergast, Áine M., Baumgärtner, Daniel, Carnevalli, Larissa S., Atzberger, Ann, Haas, Simon et al. · 2016 · Cell
  6. Tunable protein synthesis by transcript isoforms in human cells
    Floor, Stephen N, Doudna, Jennifer A · 2016 · eLife
  7. Endothelial Cells Derived From Human iPSCS Increase Capillary Density and Improve Perfusion in a Mouse Model of Peripheral Arterial Disease
    Abdul Jalil Rufaihah, Ngan Fong Huang, Sina Jamé, Jerry C. Lee, Ha Nam Nguyen, Blake Byers, Abhijit De, Janet Okogbaa, Mark D. Rollins, Renee A. Reijo Pera et al. · 2011 · Arteriosclerosis Thrombosis and Vascular Biology
  8. Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells
    Paull, Daniel, Sevilla, Ana, Zhou, Hongyan, Hahn, Aana Kim, Kim, Hesed, Napolitano, Christopher, Tsankov, Alexander, Shang, Linshan, Krumholz, Katie, Jagadeesan, Premlatha et al. · 2015 · Nature Methods
  9. A Comparative View on Human Somatic Cell Sources for iPSC Generation
    Raab, Stefanie, Klingenstein, Moritz, Liebau, Stefan, Linta, Leonhard · 2014 · Stem Cells International
  10. MicroRNA Cluster 302–367 Enhances Somatic Cell Reprogramming by Accelerating a Mesenchymal-to-Epithelial Transition
    Baojian Liao, Xichen Bao, Longqi Liu, Shipeng Feng, Athanasios Zovoilis, Wenbo Liu, Yanting Xue, Jie Cai, Xiangpeng Guo, Baoming Qin et al. · 2011 · Journal of Biological Chemistry
  11. Current status of pluripotent stem cells: moving the first therapies to the clinic
    Erin A. Kimbrel, Robert Lanza · 2015 · Nature Reviews Drug Discovery
  12. Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification
    Vaidyanathan, Sriram, Azizian, Krist T., Haque, A.K.M. Ashiqul, Henderson, Jordana M., Hendel, Ayal, Shore, Sabrina, Antony, Justin S., Hogrefe, Richard I., Kormann, Michael S.D., Porteus, Matthew H. et al. · 2018 · Molecular Therapy Nucleic Acids
  13. Tissue Engineering and Regenerative Medicine: Recent Innovations and the Transition to Translation
    Matthew B. Fisher, Robert L. Mauck · 2012 · Tissue Engineering Part B Reviews
  14. A Simple Bioreactor-Based Method to Generate Kidney Organoids from Pluripotent Stem Cells
    Aneta J. Przepiorski, Veronika Sander, Tracy Tran, Jennifer A. Hollywood, Brie Sorrenson, Jen‐Hsing Shih, Ernst Jurgen Wolvetang, Andrew P. McMahon, Teresa M. Holm, Alan James Davidson · 2018 · Stem Cell Reports
  15. Lipid nanoparticles for delivery of messenger RNA to the back of the eye
    Patel, Siddharth, Ryals, Renee C., Weller, Kyle K., Pennesi, Mark E., Sahay, Gaurav · 2019 · Journal of Controlled Release
  16. Induced pluripotent stem cells: opportunities and challenges
    Keisuke Okita, Shinya Yamanaka · 2011 · Philosophical Transactions of the Royal Society B Biological Sciences
  17. Direct lineage conversions: unnatural but useful?
    Vierbuchen, Thomas, Wernig, Marius · 2011 · Nature Biotechnology
  18. Modeling Neural Crest Induction, Melanocyte Specification, and Disease-Related Pigmentation Defects in hESCs and Patient-Specific iPSCs
    Yvonne Mica, Gabsang Lee, Stuart M. Chambers, Mark J. Tomishima, Lorenz Studer · 2013 · Cell Reports
  19. Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming.
    Eva Warlich, J. Kuehle, T. Cantz, M. Brugman, T. Maetzig, M. Galla, A. Filipczyk, S. Halle, H. Klump, H. Schöler et al. · 2011 · Molecular Therapy
  20. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels
    Andriana Margariti, Bernhard Winkler, Eirini Karamariti, Anna Zampetaki, Tsung-Neng Tsai, Dilair F. Baban, Jiannis Ragoussis, Yi Cheng Huang, Jing‐Dong J. Han, Lingfang Zeng et al. · 2012 · Proceedings of the National Academy of Sciences
  21. Stem cells in retinal regeneration: past, present and future
    Conor M. Ramsden, Michael Barry Powner, Amanda‐Jayne F. Carr, Matthew J. K. Smart, Lyndon da Cruz, Peter J. Coffey · 2013 · Development
  22. Efficient Feeder-Free Episomal Reprogramming with Small Molecules
    Junying Yu, Kevin Fongching Chau, Maxim A. Vodyanik, Jinlan Jiang, Yong Jiang · 2011 · PLoS ONE
  23. Aging in a Dish: iPSC-Derived and Directly Induced Neurons for Studying Brain Aging and Age-Related Neurodegenerative Diseases
    Jérôme Mertens, Dylan A. Reid, Shong Lau, Yongsung Kim, Fred H. Gage · 2018 · Annual Review of Genetics
  24. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells
    Kejin Hu, Junying Yu, Kran Suknuntha, Shulan Tian, Karen Dyer Montgomery, Kyung-Dal Choi, Ron M. Stewart, James Alexander Thomson, Igor I. Slukvin · 2011 · Blood
  25. Programming human pluripotent stem cells into white and brown adipocytes
    Tim Ahfeldt, R. Schinzel, Youn-Kyoung Lee, David G. Hendrickson, Adam Kaplan, David H. Lum, Raymond Camahort, Fang Xia, Jennifer Shay, E. Rhee et al. · 2012 · Nature Cell Biology
  26. Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1
    Wei Wang, Jian Ping Yang, Hui Liu, Dong Lu, Xiongfeng Chen, Ζήνων Ζήνωνος, Lia S. Campos, Roland Rad, Ge Guo, Shujun Zhang et al. · 2011 · Proceedings of the National Academy of Sciences
  27. Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
    Zhang, Lizhou, More, Kunal R., Ojha, Amrita, Jackson, Cody B., Quinlan, Brian D., Li, Hao, He, Wenhui, Farzan, Michael, Pardi, Norbert, Choe, Hyeryun · 2023 · npj Vaccines
  28. Large-Scale Analysis Reveals Acquisition of Lineage-Specific Chromosomal Aberrations in Human Adult Stem Cells
    Uri Ben‐David, Yoav Mayshar, Nissim Benvenisty · 2011 · Cell stem cell
  29. Genetic and epigenetic stability of human pluripotent stem cells
    Riikka Lund, Elisa Närvä, Riitta Lahesmaa · 2012 · Nature Reviews Genetics
  30. Towards regenerative therapy for cardiac disease
    Leon M. Ptaszek, Moussa Mansour, Jeremy Neil Ruskin, Kenneth R. Chien · 2012 · The Lancet
  31. RNAs containing modified nucleotides fail to trigger RIG-I conformational changes for innate immune signaling
    Durbin, Ann Fiegen, Wang, Chen, Marcotrigiano, Joseph, Gehrke, Lee · 2016 · mBio
  32. Digital logic circuits in yeast with CRISPR-dCas9 NOR gates
    Miles W. Gander, Justin D. Vrana, William E. Voje, James M. Carothers, Eric Klavins · 2017 · Nature Communications
  33. Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy In Vitro
    Akihito Tanaka, Knut Woltjen, Katsuya Miyake, Akitsu Hotta, Makoto Ikeya, Takuya Yamamoto, Tokiko Nishino, Emi Shoji, Atsuko Sehara‐Fujisawa, Yasuko Manabe et al. · 2013 · PLoS ONE
  34. Biological roles of RNA m5C modification and its implications in Cancer immunotherapy
    Hang Song, Jianye Zhang, Bin Liu, Jing Xu, Biao Cai, Hai Yang, Julia Straube, Xiyong Yu, Teng Ma · 2022 · Biomarker Research
  35. Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease–mediated safe harbor targeting
    Jizhong Zou, Colin L. Sweeney, Bin-Kuan Chou, Uimook Choi, Jason Pan, Hongmei Wang, Sarah N. Dowey, Linzhao Cheng, Harry L. Malech · 2011 · Blood
  36. m5C Methylation Guides Systemic Transport of Messenger RNA over Graft Junctions in Plants
    Lei Yang, Valentina Perrera, Eleftheria Saplaoura, Federico Apelt, Mathieu Bahin, Amira Kramdi, Justyna Jadwiga Olas, Bernd Mueller‐Roeber, Ewelina Sokołowska, Wenna Zhang et al. · 2019 · Current Biology
  37. Cap 1 Messenger RNA Synthesis with Co‐transcriptional CleanCap <sup>®</sup> Analog by In Vitro Transcription
    Henderson, Jordana M., Ujita, Andrew, Hill, Elizabeth, Yousif‐Rosales, Sally, Smith, Cory, Ko, Nicholas, McReynolds, Taylor, Cabral, Charles R., Escamilla‐Powers, Julienne R., Houston, Michael E. · 2021 · Current Protocols
  38. Bone tissue engineering: state of the union
    Arun R. Shrivats, Michael C. McDermott, Jeffrey O. Hollinger · 2014 · Drug Discovery Today
  39. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association
    Kiran Musunuru, Farah Sheikh, Rajat M. Gupta, Steven R. Houser, Kevin Maher, David J. Milan, André Terzic, Joseph C. Wu · 2018 · Circulation Genomic and Precision Medicine
  40. Characterizing 5-methylcytosine in the mammalian epitranscriptome
    Shobbir Hussain, Jelena Aleksic, Sandra Blanco, Sabine Dietmann, Michaela Frye · 2013 · Genome biology
  41. Non-genetic engineering of cells for drug delivery and cell-based therapy
    Wang, Qun, Cheng, Hao, Peng, Haisheng, Zhou, Hao, Li, Peter Y., Langer, Robert · 2015 · Advanced Drug Delivery Reviews
  42. Pluripotent Stem Cells: Current Understanding and Future Directions
    Antonio Romito, Gilda Cobellis · 2015 · Stem Cells International
  43. Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
    Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, Alicia Rodríguez‐Gascón, Maria Ángelés Solinís, Ana del Pozo‐Rodríguez · 2020 · Nanomaterials
  44. Induced Pluripotent Stem Cells as a Disease Modeling and Drug Screening Platform
    Antje Ebert, Ping Liang, Joseph C. Wu · 2012 · Journal of Cardiovascular Pharmacology
  45. The Use of Induced Pluripotent Stem Cells in Drug Development
    Haruhisa Inoue, Shinya Yamanaka · 2011 · Clinical Pharmacology & Therapeutics
  46. Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches
    Kenji Miki, Kei Endo, Seiya Takahashi, Shunsuke Funakoshi, Ikue Takei, Shota Katayama, Tarō Toyoda, Maki Kotaka, Tadashi Takaki, Masayuki Umeda et al. · 2015 · Cell stem cell
  47. Formulation and Delivery Technologies for mRNA Vaccines
    Chunxi Zeng, Chengxiang Zhang, Patrick G. Walker, Yizhou Dong · 2020 · Current topics in microbiology and immunology
  48. Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT–MET mechanism for optimal reprogramming
    Xiaopeng Liu, Hao Sun, Jing Yu Qi, Linli Wang, Songwei He, Jing Liu, Chengqian Feng, Chunlan Chen, Wen Li, Yunqian Guo et al. · 2013 · Nature Cell Biology
  49. Reprogramming human fibroblasts to pluripotency using modified mRNA
    P. Mandal, Derrick J. Rossi · 2013 · Nature Protocols
  50. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening
    Pedro Pires Goulart Guimarães, Rui Zhang, Roman Spektor, Mingchee Tan, Amanda Chung, Margaret M. Billingsley, Rakan D. El-Mayta, Rachel Riley, Lili Wang, James M. Wilson et al. · 2019 · Journal of Controlled Release
  51. Stem Cell Therapy in Heart Diseases – Cell Types, Mechanisms and Improvement Strategies
    Paula Müller, Heiko Lemcke, Robert David · 2018 · Cellular Physiology and Biochemistry
  52. An origin of the immunogenicity of in vitro transcribed RNA
    Mu, Xin, Greenwald, Emily, Ahmad, Sadeem, Hur, Sun · 2018 · Nucleic Acids Research
  53. Human iPSC banking: barriers and opportunities
    Ching‐Ying Huang, Chun-Lin Liu, Chien-Yu Ting, Yueh-Ting Chiu, Yu‐Che Cheng, Martin W. Nicholson, Patrick C.H. Hsieh · 2019 · Journal of Biomedical Science
  54. How to make a functional β-cell
    F. Pagliuca, D. Melton · 2013 · Development
  55. Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
    Jilian R. Melamed, Saigopalakrishna S. Yerneni, Mariah Lynn Arral, Samuel T. LoPresti, Namit Chaudhary, Anuradha Sehrawat, Hiromi Muramatsu, Mohamad‐Gabriel Alameh, Norbert Pardi, Drew Weissman et al. · 2023 · Science Advances
  56. The let-7/LIN-41 Pathway Regulates Reprogramming to Human Induced Pluripotent Stem Cells by Controlling Expression of Prodifferentiation Genes
    Kathleen A. Worringer, Tim Rand, Yohei Hayashi, Salma Sami, Kazutoshi Takahashi, Koji Tanabe, Megumi Narita, Deepak Srivastava, Shinya Yamanaka · 2013 · Cell stem cell
  57. Pluripotent stem cell energy metabolism: an update
    Tara A. TeSlaa, Michael A. Teitell · 2014 · The EMBO Journal
  58. mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation
    Oren Levy, Weian Zhao, Luke J. Mortensen, Sarah LeBlanc, Kyle Tsang, Moyu Fu, Joseph A. Phillips, Vinay Sagar, Priya N. Anandakumaran, Jessica Ngai et al. · 2013 · Blood
  59. Naturally occurring modified ribonucleosides
    Phillip J. McCown, Agnieszka Ruszkowska, Charlotte N. Kunkler, Kurtis Breger, Jacob P. Hulewicz, Matthew C. Wang, Noah A. Springer, Jessica A. Brown · 2020 · Wiley Interdisciplinary Reviews - RNA
  60. Pseudouridine: Still mysterious, but never a fake (uridine)!
    Felix Spenkuch, Yuri Motorin, Mark Helm · 2014 · RNA Biology
  61. Lipid-based mRNA vaccine delivery systems
    Patrick Midoux, Chantal Pichon · 2014 · Expert Review of Vaccines
  62. Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine
    Kwon, Hyokyoung, Kim, Minjeong, Seo, Yunmi, Moon, Yae Seul, Lee, Hwa Jeong, Lee, Kyuri, Lee, Hyukjin · 2018 · Biomaterials
  63. N6-methyl-adenosine modification in messenger and long non-coding RNA
    Tao Pan · 2013 · Trends in Biochemical Sciences
  64. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications
    Adekunle Ebenezer Omole, Adegbenro Omotuyi John Fakoya · 2018 · PeerJ
  65. mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma
    Wang, Yuhua, Zhang, Lu, Xu, Zhenghong, Miao, Lei, Huang, Leaf · 2018 · Molecular Therapy
  66. How mRNA therapeutics are entering the monoclonal antibody field
    Van Hoecke, Lien, Roose, Kenny · 2019 · Journal of Translational Medicine
  67. Molecular and Cellular Regulation of Skeletal Myogenesis
    Glenda Comai, Shahragim Tajbakhsh · 2014 · Current topics in developmental biology/Current Topics in Developmental Biology
  68. In Vitro Transcription of Long RNA Containing Modified Nucleosides
    Norbert Pardi, Hiromi Muramatsu, Drew Weissman, Katalin Karikó · 2012 · Methods in molecular biology
  69. A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells
    Stephanie I. Protze, Shahryar Khattak, Claire E. Poulet, Dirk Lindemann, Elly Margaret Tanaka, Ursula Ravens · 2012 · Journal of Molecular and Cellular Cardiology
  70. Engineering bone tissue substitutes from human induced pluripotent stem cells
    Giuseppe Maria de Peppo, Iván Marcos-Campos, David J. Kahler, Dana Alsalman, Linshan Shang, Gordana Vunjak‐Novakovic, Darja Marolt · 2013 · Proceedings of the National Academy of Sciences
  71. Drug and cell delivery for cardiac regeneration
    Conn L. Hastings, Ellen Tunney Roche, Eduardo Ruiz‐Hernández, Katja Schenke‐Layland, Conor J. Walsh, Garry P. Duffy · 2014 · Advanced Drug Delivery Reviews
  72. Background Mutations in Parental Cells Account for Most of the Genetic Heterogeneity of Induced Pluripotent Stem Cells
    Margaret A. Young, David E. Larson, Chiao‐Wang Sun, Daniel R. George, Li Ding, Christopher A. Miller, Ling Lin, Kevin M. Pawlik, Ken Chen, Xian Fan et al. · 2012 · Cell stem cell
  73. Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy
    Ioannis Karakikes, Francesca Stillitano, Mathieu E. Nonnenmacher, Christos Tzimas, Despina Sanoudou, Vittavat Termglinchan, Chi‐Wing Kong, Stephanie N. Rushing, Jens Hansen, Delaine K. Ceholski et al. · 2015 · Nature Communications
  74. Tapping the RNA world for therapeutics
    Judy Lieberman · 2018 · Nature Structural & Molecular Biology
  75. Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells
    Xinjian Liu, Li Fang, Elizabeth A. Stubblefield, Barbara C. Blanchard, Toni L. Richards, Gaynor A. Larson, Yujun He, Qian Huang, Aik Choon Tan, Dabing Zhang et al. · 2011 · Cell Research
  76. Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro
    Kensah, George, Roa Lara, Angelica, Dahlmann, Julia, Zweigerdt, Robert, Schwanke, Kristin, Hegermann, Jan, Skvorc, David, Gawol, Anke, Azizian, Azadeh, Wagner, Stefan et al. · 2013 · European Heart Journal
  77. Induced pluripotent stem cells: at the heart of cardiovascular precision medicine
    Chen, Ian Y., Matsa, Elena, Wu, Joseph C. · 2016 · Nature Reviews Cardiology
  78. Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo
    Kevin J. Kauffman, Faryal F. Mir, Siddharth Jhunjhunwala, James C. Kaczmarek, Juan E. Hurtado, Jung H. Yang, Matthew J. Webber, Piotr S. Kowalski, Michael W. Heartlein, Frank DeRosa et al. · 2016 · Biomaterials
  79. Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape
    Bernadett Papp, Kathrin Plath · 2011 · Cell Research
  80. CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
    Hannah M. Knochelmann, Aubrey S. Smith, Connor J. Dwyer, Megan M. Wyatt, Shikhar Mehrotra, Chrystal Mary Paulos · 2018 · Frontiers in Immunology
  81. Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises
    Maria Carolina Marchetto, Kristen Brennand, Leah F. Boyer, Fred H. Gage · 2011 · Human Molecular Genetics
  82. Mesenchymal stem cells in the dental tissues: perspectives for tissue regeneration
    Carlos Estrela, Ana Helena Gonçalves de Alencar, Gregory Thomas Kitten, Eneida Franco Vêncio, Elisandra Gava · 2011 · Brazilian Dental Journal
  83. Applications of synthetic biology in medical and pharmaceutical fields
    Xu Yan, Xu Liu, Cuihuan Zhao, Guo‐Qiang Chen · 2023 · Signal Transduction and Targeted Therapy
  84. m6A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic Development
    Yimeng Gao, Radovan Vasic, Yuanbin Song, Rhea W. Teng, Chengyang Liu, Rana Gbyli, Giulia Biancon, Raman V. Nelakanti, Kirsten Lobben, Eriko Kudo et al. · 2020 · Immunity
  85. Generating a Non-Integrating Human Induced Pluripotent Stem Cell Bank from Urine-Derived Cells
    Yanting Xue, Xiujuan Cai, Linli Wang, Baojian Liao, Hui Zhang, Yongli Shan, Qianyu Chen, Tiancheng Zhou, Xirui Li, Jundi Hou et al. · 2013 · PLoS ONE
  86. Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy.
    Yu-Hua Wang, Hsing-Hao Su, Yang Yang, Yun-Xia Hu, Lu Zhang, P. Blancafort, Leaf Huang · 2013 · Molecular Therapy
  87. Targeted Disruption of the β2‐Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells
    Da-Chun Wang, Y. Quan, Qing Yan, John E. Morales, Rick A. Wetsel · 2015 · Stem Cells Translational Medicine
  88. HPLC purification of in vitro transcribed long RNA
    Weissman, Drew, Pardi, Norbert, Muramatsu, Hiro, Karikó, Katalin · 2013 · Methods in molecular biology
  89. Platform for Induction and Maintenance of Transgene-free hiPSCs Resembling Ground State Pluripotent Stem Cells
    Bahram Bob Valamehr, Megan Robinson, Ramzey Abujarour, Betsy Rezner, Florin Vranceanu, Thuy My Le, Amanda Medcalf, Tom Tong Lee, Michael Fitch, David Robbins et al. · 2014 · Stem Cell Reports
  90. RNA circles with minimized immunogenicity as potent PKR inhibitors
    Chu‐Xiao Liu, Si-Kun Guo, Nan Fang, Yi-Feng Xu, Li Chun Yang, Ling‐Ling Chen · 2021 · Molecular Cell
  91. Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines
    Raquel P. Deering, Sushma Kommareddy, Jeffrey B. Ulmer, Luis A. Brito, Andrew J. Geall · 2014 · Expert Opinion on Drug Delivery
  92. Present and future challenges of induced pluripotent stem cells
    Mari Ohnuki, Kazutoshi Takahashi · 2015 · Philosophical Transactions of the Royal Society B Biological Sciences
  93. RNA-dependent chromatin targeting of TET2 for endogenous retrovirus control in pluripotent stem cells
    Diana Guallar, Xianju Bi, José Ángel Pardavila, Xin Huang, Carmen Sáenz, Xianle Shi, Hongwei Zhou, Francesco Faiola, Junjun Ding, Phensinee Haruehanroengra et al. · 2018 · Nature Genetics
  94. Non-liver mRNA Delivery
    Loughrey, David, Dahlman, James E. · 2022 · Accounts of Chemical Research
  95. iPS cells: A source of cardiac regeneration
    Yoshinori Yoshida, Shinya Yamanaka · 2010 · Journal of Molecular and Cellular Cardiology
  96. Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression
    Sarah N. Dowey, Xiaosong Huang, Bin-Kuan Chou, Zhaohui Ye, Linzhao Cheng · 2012 · Nature Protocols
  97. Crosstalk between stem cell and spinal cord injury: pathophysiology and treatment strategies
    Anwen Shao, Sheng Tu, Jianan Lü, Jianmin Zhang · 2019 · Stem Cell Research & Therapy
  98. Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells
    Dongrui Ma, Heming Wei, Yongxing Zhao, Jun Lü, Guang Li, Norliza Binte Esmail Sahib, Teng Hong Tan, Keng Yean Wong, WINSTON S. N. SHIM, Philip Wong et al. · 2013 · International Journal of Cardiology
  99. Development of human embryonic stem cell therapies for age-related macular degeneration
    Amanda‐Jayne F. Carr, Matthew J. K. Smart, Conor M. Ramsden, Michael Barry Powner, Lyndon da Cruz, Peter J. Coffey · 2013 · Trends in Neurosciences
  100. Functional Vascular Endothelium Derived from Human Induced Pluripotent Stem Cells
    William James Adams, Yuzhi Zhang, Jennifer K. Cloutier, Pranati Kuchimanchi, Gail A. Newton, Seema Sehrawat, William C. Aird, Tanya N. Mayadas, Francis William Luscinskas, Guillermo García‐Cardeña · 2013 · Stem Cell Reports